UK pharma downbeat on its future – survey

November 8, 2011
Research and Development ABPI, R&D, VBP, rsa

The impacts of NHS reform and the increasingly high cost of R&D is causing pharma to doubt its future in …

Organising a successful event

November 8, 2011
Sales and Marketing

Company conferences and events have come a long way since we used to be taken out for a short meeting …

Market access โ€“ looking back

November 8, 2011
Sales and Marketing

Market access is complicated. Multifaceted, multi-discipline, multidimensional, multi-stake-holder, all these multiples make Market Access one of the most challenging and …

Daniel Grau appointed as president of Heptares

November 8, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daniel Grau, Heptares

Daniel Grau has been appointed as president of Heptares Therapeutics, a specialist in G-protein-coupled receptors.  Mr Grau has been a …

Pfizer Sandwich image

Pfizer to retain an extra 300 jobs at Sandwich site

November 8, 2011
Manufacturing and Production, Research and Development Jobs, Pfizer, Sandwich

Pfizer will now keep up to 650 jobs at its R&D site in Sandwich, Kent, according to news reports. The …

TranslatePharma now partnered with European Regulatory Solutions

November 8, 2011

As a part of the ERA Consultancy Group, European Regulatory Solutions (ERS) specialise in offering consultancy services and regulatory advice …

GSK taps Alnylam tech for vaccine production

November 7, 2011
Manufacturing and Production, Sales and Marketing Alnylam, GSK, vaccines

GlaxoSmithKline has teamed up with gene silencing specialist Alnylam Pharmaceuticals in a project aimed at speeding up the production of …

Bosch planning second packaging plant in China

November 7, 2011
Manufacturing and Production Bosch, China

Bosch Packaging Technology has decided to boost its presence in Asia with the construction of a second plant in the …

Contract research news in brief

November 7, 2011
Manufacturing and Production

No new suitors come forward for PPD, Icon and Charles River report mixed Q3 results, plus updates from Cyprotex and …

david_roblin__picture_o

Ex-Pfizer R&D head Dr David Roblin joins Destiny Pharma

November 7, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Destiny Pharma, Pfizer, R&D

Anti-microbial drug developers Destiny Pharma have appointed Dr David Roblin as its new medical director. Dr Roblin was formerly head …

Aslan licences promising cancer drug from Bristol-Myers Squibb

November 7, 2011
Research and Development, Sales and Marketing Aslan, BMS, Cancer

Bristol-Myers Squibb has licensed one of its investigational oncology compounds, for the treatment of multiple solid tumours, to Singapore-based Aslan …

Xarelto gains lucrative new licence from FDA

November 7, 2011
Sales and Marketing

The FDA has approved Bayer/J&Jโ€™s Xarelto once-daily pill for stroke prevention in patients with an abnormal heart rhythm. The US …

Ranbayx image

Ranbaxy to collaborate with Teva on generic Lipitor in US?

November 7, 2011
Manufacturing and Production, Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva

Israeli drugmaker Teva Pharmaceutical could get an unexpected boost from an earlier-than-expected launch of its generic version of Pfizer’s cholesterol …

steve_hobbsrgb

Steve Hobbs joins Apodi senior management team

November 4, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Steve Hobbs has joined Apodiโ€™s senior management team as director of business and account development. Steve has over 30 years …

Graham Higson joins NDA Group to lead Regulatory and HTA Advisory Board

November 4, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA

GE Healthcare and ex AstraZeneca Head of Global Regulatory Affairs, Graham Higson, will join NDA Group in January 2012 to …

Hamburg FDA image

FDA boasts better approval rates than Europe

November 4, 2011
Medical Communications, Research and Development FDA, approvals

US regulator the FDA has approved more drugs and at a faster rate than its European counterpart.A new report by …

GSK, Pfizer joint venture to start manufacturing ops in Russia

November 4, 2011
Manufacturing and Production GSK, Pfizer, manufacturing

A joint venture set up by GlaxoSmithKline and Pfizer is planning to start manufacturing in Russia thanks to a partnership …

Ketchum wins International Consultancy of the Year award

November 3, 2011
Medical Communications Ketchum, Ketchum Pleon, PR

Ketchum Pleon has accepted the International Consultancy of the Year award on behalf of the global firm Ketchum at the …

GSK pays $3 billion to settle US marketing probe

November 3, 2011
Sales and Marketing GSK, compliance, federal investigation

GlaxoSmithKline has agreed to pay $3 billion to settle US government investigations into the sales and marketing of diabetes drug …

The Gateway to Local Adoption Series

Latest content